Propanc Health Group Corp. (OTCMKTS:PPCH) Recovers Some Ground

Propanc Health Group Corp. (OTCMKTS:PPCH)’s Monday spike continued into the new week as well, the ticker gaining another 12.83% in yesterday’s trading session after making an announcement.

Although the tides were obviously already turning on Monday, the announcement that PPCH “will be investigating the effects of PRP against cancer stems cells with its joint research partner at the University of Jaen, Spain” certainly had a positive effect on the company’s share prices. At the very least, the press release drew investor attention towards the company, as evidenced by the increasing dollar volume in that session.

Today’s session may well end up taking the ticker even higher, as PPCH made another announcement just minutes ago. As per this latest press release, PPCH has acquired the retainer of Maxim Group LLC, an securities and investment management and banking firm. Maxim Group is to provide strategic corporate planning and investment banking services for PPCH in the near future, and help PPCH get listed on “a nationally recognized exchange”.

How will Maxim be able to achieve that, in light of PPCH‘s unimpressive financials and its horrifying dilution statistics, remains unclear.

What is clear is the fact that investors should be wary of PPCH. The ticker’s movements are unpredictable to say the least, and its current ascent could turn into a disaster at any time.